X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Strides Arcolab with Novartis - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STRIDES SHASUN LTD vs NOVARTIS - Comparison Results

STRIDES SHASUN LTD    Change

Strides Arcolab is an Indian pharmaceutical company headquartered at Bangalore. The company is primarily involved in two businesses notably the pharma business and the specialized sterile products business branded as Agila. This segment focuses large... More

NOVARTIS 
   Change

Novartis is a 76% subsidiary of Novartis AG - Switzerland and has a countrywide presence in the healthcare business. While pharmaceuticals contributes 70% to total revenues (FY10), generics (6%), consumer healthcare i.e. OTC (14%) and animal health (... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    STRIDES SHASUN LTD NOVARTIS STRIDES SHASUN LTD/
NOVARTIS
 
P/E (TTM) x 32.5 295.9 11.0% View Chart
P/BV x 0.9 25.2 3.4% View Chart
Dividend Yield % 1.1 1.4 78.7%  

Financials

 STRIDES SHASUN LTD   NOVARTIS
EQUITY SHARE DATA
    STRIDES SHASUN LTD
Mar-17
NOVARTIS
Mar-17
STRIDES SHASUN LTD/
NOVARTIS
5-Yr Chart
Click to enlarge
High Rs1,275855 149.1%   
Low Rs918666 137.9%   
Sales per share (Unadj.) Rs389.6219.0 177.9%  
Earnings per share (Unadj.) Rs28.019.1 146.4%  
Cash flow per share (Unadj.) Rs48.920.3 240.9%  
Dividends per share (Unadj.) Rs4.5010.00 45.0%  
Dividend yield (eoy) %0.41.3 31.2%  
Book value per share (Unadj.) Rs303.1307.0 98.7%  
Shares outstanding (eoy) m89.4229.96 298.5%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x2.83.5 81.1%   
Avg P/E ratio x39.239.8 98.5%  
P/CF ratio (eoy) x22.437.5 59.9%  
Price / Book Value ratio x3.62.5 146.0%  
Dividend payout %16.152.4 30.7%   
Avg Mkt Cap Rs m98,03622,779 430.4%   
No. of employees `0005.80.7 860.5%   
Total wages/salary Rs m5,8811,393 422.2%   
Avg. sales/employee Rs Th6,005.99,736.2 61.7%   
Avg. wages/employee Rs Th1,014.02,066.8 49.1%   
Avg. net profit/employee Rs Th431.2849.0 50.8%   
INCOME DATA
Net Sales Rs m34,8346,562 530.8%  
Other income Rs m1,686702 240.3%   
Total revenues Rs m36,5207,264 502.8%   
Gross profit Rs m6,428259 2,482.8%  
Depreciation Rs m1,87236 5,213.1%   
Interest Rs m2,2697 31,518.1%   
Profit before tax Rs m3,973917 433.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m40-   
Extraordinary Inc (Exp) Rs m-1,0060-   
Tax Rs m470345 136.2%   
Profit after tax Rs m2,501572 437.1%  
Gross profit margin %18.53.9 467.7%  
Effective tax rate %11.837.6 31.4%   
Net profit margin %7.28.7 82.3%  
BALANCE SHEET DATA
Current assets Rs m38,1659,731 392.2%   
Current liabilities Rs m30,4021,830 1,660.9%   
Net working cap to sales %22.3120.4 18.5%  
Current ratio x1.35.3 23.6%  
Inventory Days Days7749 158.8%  
Debtors Days Days10425 415.3%  
Net fixed assets Rs m37,63957 65,802.8%   
Share capital Rs m894141 635.5%   
"Free" reserves Rs m26,2109,056 289.4%   
Net worth Rs m27,1059,196 294.7%   
Long term debt Rs m16,3770-   
Total assets Rs m81,16811,499 705.8%  
Interest coverage x2.8128.4 2.1%   
Debt to equity ratio x0.60-  
Sales to assets ratio x0.40.6 75.2%   
Return on assets %5.95.0 116.6%  
Return on equity %9.26.2 148.3%  
Return on capital %12.110.1 119.9%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m13,465129 10,446.2%   
Fx outflow Rs m4,0761,734 235.1%   
Net fx Rs m9,389-1,605 -585.0%   
CASH FLOW
From Operations Rs m2,881-380 -759.3%  
From Investments Rs m-7,0514,208 -167.6%  
From Financial Activity Rs m3,382-3,318 -101.9%  
Net Cashflow Rs m-788510 -154.4%  

Share Holding

Indian Promoters % 27.7 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 37.8 2.0 1,890.0%  
FIIs % 8.6 1.6 537.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.9 21.5 120.5%  
Shareholders   56,241 41,647 135.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare STRIDES SHASUN LTD With:   JUBILANT LIFE SCIENCES  DR. DATSONS LABS  CADILA HEALTHCARE  GSK PHARMA  UNICHEM LAB  

Compare STRIDES SHASUN LTD With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Day up 260 Points; Pharma Stocks Top Gainers(Closing)

After opening the day in red, share markets in India witnessed positive trading activity throughout the day and ended the day on a positive note.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Alert: Pharma Stocks Are About to Shoot Up - And a Superb Stock for Trading(Profit Hunter)

Jun 13, 2018

The ailing pharma stocks are bouncing back to health. Read this to find out the best way to profit from them.

Will You Dump Your Client if You're Busy? Inox Wind's Auditor Just Did...(The 5 Minute Wrapup)

Jun 14, 2018

After Inox Wind, you may see more auditors resigning And the reasons can be as funny as they can get.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Should You Invest In Mirae Asset Healthcare Fund?(Outside View)

Jun 15, 2018

Mirae Asset Mutual Fund launches NFO - Mirae Asset Helathcare Fund.

Has the Market Bottomed Out?(Sector Info)

Jun 11, 2018

The yield spread is an effective barometer that can indicate the direction the markets are headed.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

STRIDES SHASUN LTD SHARE PRICE


Jun 22, 2018 (Close)

TRACK STRIDES SHASUN LTD

  • Track your investment in STRIDES SHASUN LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STRIDES SHASUN LTD

STRIDES SHASUN LTD - ORCHID PHARMA LTD COMPARISON

COMPARE STRIDES SHASUN LTD WITH

MARKET STATS